|
|
|
|
|
AstrazenecaAstraZeneca PLC, is a large Anglo-Swedish pharmaceutical company formed on 6 April 1999 by the merger of Swedish Astra AB and British Zeneca Group PLC. Zeneca was originally known as Imperial Chemical Industries prior to a demerger in 1993. AstraZeneca develops, manufactures, and sells pharmaceuticals to treat disorders in the gastrointestinal, cardiac and vascular, neurological and psychiatric, infection, respiratory, pathological inflammation and oncology areas. Sales in 2003 totalled $18.8 billion, with a profit before tax of $4.2 billion. Total R&D spending was $3.5 billion. The corporate headquarters are in London, UK, the research and development (R&D) headquarters are in Sdertlje, Sweden. Major R&D centres are located on three continents in the United States, United Kingdom, Sweden, and India. The current chief executive of AstraZeneca is Sir Tom McKillop. Products AstraZeneca specialises in prescription medicines to fight disease in the several therapeutic areas. Year-on sales information can be found through AstraZeneca annual reports. The following is a list of key products as found on the AstraZeneca US website, retrieved 2005-03-27. Diversity AstraZeneca is one of the 100 Best Companies for Working Mothers in 2004 according to Working Mothers magazine. See also References - AstraZeneca - History, merger of Astra AB and Zeneca Group PLC, part of the AstraZeneca home site. Retrieved 2005-03-20. (merger and post-merger history)
- AstraZeneca: Merger partners in brief, part of the AstraZeneca home site. Retrieved 2005-03-20. (history of Astra AB and Zeneca Group PLC)
External links
|
 |
|
| Copyright 2005-2009 OnPedia.com. All Rights Reserved |
|
|